Enorama Pharma AB (publ) (STO:ERMA)

Market Cap	25.29M -84.5%
Revenue (ttm)	2.18M -86.6%
Net Income	-65.27M
EPS	-0.90
Shares Out	74.59M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,982
Open	0.3360
Previous Close	0.3390
Day's Range	0.3360 - 0.3440
52-Week Range	0.2110 - 3.5800
Beta	1.69
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About Enorama Pharma AB

Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells medicated chewing gum in Sweden. It offers nicotine chewing gum and nicotine pouches under the NIC-S brand name. The company was incorporated in 2006 and is based in Malmö, Sweden.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2006
• Employees: 4
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: ERMA

Financial Performance

In 2025, Enorama Pharma AB's revenue was 2.74 million, a decrease of -82.63% compared to the previous year's 15.77 million. Losses were -75.14 million, 71.5% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 16, 2026

Data Sources Report a data error